187 related articles for article (PubMed ID: 16266199)
1. Low-dose ethinylestradiol/levonorgestrel.
Dando TM; Curran MP
Drugs; 2005; 65(16):2299-306; discusion 2307-8. PubMed ID: 16266199
[TBL] [Abstract][Full Text] [Related]
2. A multicenter, uncontrolled clinical investigation of the contraceptive efficacy, cycle control, and safety of a new low dose oral contraceptive containing 20 micrograms ethinyl estradiol and 100 micrograms levonorgestrel over six treatment cycles.
Bannemerschult R; Hanker JP; Wünsch C; Fox P; Albring M; Brill K
Contraception; 1997 Nov; 56(5):285-90. PubMed ID: 9437556
[TBL] [Abstract][Full Text] [Related]
3. Extended-Cycle Levonorgestrel/Ethinylestradiol and Low-Dose Ethinylestradiol (Seasonique(®)): A Review of Its Use as an Oral Contraceptive.
Burness CB
Drugs; 2015 Jun; 75(9):1019-26. PubMed ID: 26017303
[TBL] [Abstract][Full Text] [Related]
4. Multicenter, comparative study of cycle control, efficacy and tolerability of two low-dose oral contraceptives containing 20 microg ethinylestradiol/100 microg levonorgestrel and 20 microg ethinylestradiol/500 microg norethisterone.
Endrikat J; Hite R; Bannemerschult R; Gerlinger C; Schmidt W
Contraception; 2001 Jul; 64(1):3-10. PubMed ID: 11535206
[TBL] [Abstract][Full Text] [Related]
5. Efficacy and safety of a low-dose monophasic combination oral contraceptive containing 100 microg levonorgestrel and 20 microg ethinyl estradiol (Alesse). North american Levonorgestrel Study Group (NALSG).
Archer DF; Maheux R; DelConte A; O'Brien FB
Am J Obstet Gynecol; 1999 Nov; 181(5 Pt 2):39-44. PubMed ID: 10561674
[TBL] [Abstract][Full Text] [Related]
6. Continuous-use ethinylestradiol/levonorgestrel 20microg/90microg: as an oral contraceptive.
Wagstaff AJ
Drugs; 2007; 67(16):2473-7; discussion 2478-9. PubMed ID: 17983260
[TBL] [Abstract][Full Text] [Related]
7. A multicenter comparative trial of triphasic and monophasic, low-dose combined oral contraceptives.
Dunson TR; McLaurin VL; Aguayo EL; de Silva P; Calventi V; Gerais AS; Serani RG
Contraception; 1993 Jun; 47(6):515-25. PubMed ID: 8334888
[TBL] [Abstract][Full Text] [Related]
8. Clinical and biochemical investigations of a variable-dose combined type oral contraceptive.
Briggs MH; Briggs M
Curr Med Res Opin; 1977; 5(3):213-6. PubMed ID: 162656
[TBL] [Abstract][Full Text] [Related]
9. A new low-dose monophasic combination oral contraceptive (Alesse) with levonorgestrel 100 micrograms and ethinyl estradiol 20 micrograms. North American Levonorgestrel Study Group (NALSG).
Archer DF; Maheux R; DelConte A; O'Brien FB
Contraception; 1997 Mar; 55(3):139-44. PubMed ID: 9115001
[TBL] [Abstract][Full Text] [Related]
10. Pharmacodynamic and pharmacokinetic evaluation of coadministration of lacosamide and an oral contraceptive (levonorgestrel plus ethinylestradiol) in healthy female volunteers.
Cawello W; Rosenkranz B; Schmid B; Wierich W
Epilepsia; 2013 Mar; 54(3):530-6. PubMed ID: 23360419
[TBL] [Abstract][Full Text] [Related]
11. Quartette: an ascending-dose, extended-cycle oral contraceptive.
Med Lett Drugs Ther; 2013 Jul; 55(1420):54-5. PubMed ID: 23836372
[No Abstract] [Full Text] [Related]
12. Ethinylestradiol + etonogestrel contraceptive vaginal ring: new drug. Possibly useful in some situations.
Prescrire Int; 2006 Apr; 15(82):50-3. PubMed ID: 16604729
[TBL] [Abstract][Full Text] [Related]
13. Effects of second and third generation oral contraceptives and their respective progestagens on the coagulation system in the absence or presence of the factor V Leiden mutation.
Kemmeren JM; Algra A; Meijers JC; Bouma BN; Grobbee DE
Thromb Haemost; 2002 Feb; 87(2):199-205. PubMed ID: 11859850
[TBL] [Abstract][Full Text] [Related]
14. Ethinylestradiol + norelgestromin: new preparation. Transdermal contraception: no tangible progress.
Prescrire Int; 2004 Aug; 13(72):123-6. PubMed ID: 15532134
[TBL] [Abstract][Full Text] [Related]
15. Clinical comparative study of oral contraceptives containing 30 microg ethinylestradiol/150 microg levonorgestrel, and 35 microg ethinylestradiol/250 microg norgestimate in Thai women.
Tantbirojn P; Taneepanichskul S
Contraception; 2002 Dec; 66(6):401-5. PubMed ID: 12499031
[TBL] [Abstract][Full Text] [Related]
16. A multicenter randomized comparison of cycle control and laboratory findings with oral contraceptive agents containing 100 microg levonorgestrel with 20 microg ethinyl estradiol or triphasic norethindrone with ethinyl estradiol.
Reisman H; Martin D; Gast MJ
Am J Obstet Gynecol; 1999 Nov; 181(5 Pt 2):45-52. PubMed ID: 10561675
[TBL] [Abstract][Full Text] [Related]
17. Continuous, daily levonorgestrel/ethinyl estradiol vs. 21-day, cyclic levonorgestrel/ethinyl estradiol: efficacy, safety and bleeding in a randomized, open-label trial.
Teichmann A; Apter D; Emerich J; Greven K; Klasa-Mazurkiewicz D; Melis GB; Spaczynski M; Grubb GS; Constantine GD; Spielmann D
Contraception; 2009 Dec; 80(6):504-11. PubMed ID: 19913143
[TBL] [Abstract][Full Text] [Related]
18. [Escapelle - a method of choice for emergency contraception ].
Tanchev L
Akush Ginekol (Sofiia); 2008; 47 Suppl 2():24-7. PubMed ID: 19496450
[No Abstract] [Full Text] [Related]
19. An open-label randomized comparative study of oral contraceptives between medications containing 3 mg drospirenone/30 microg ethinylestradiol and 150 microg levonogestrel/30 microg ethinylestradiol in Thai women.
Suthipongse W; Taneepanichskul S
Contraception; 2004 Jan; 69(1):23-6. PubMed ID: 14720615
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of a continuous regimen of levonorgestrel/ethinyl estradiol: phase 3 study results.
Archer DF; Jensen JT; Johnson JV; Borisute H; Grubb GS; Constantine GD
Contraception; 2006 Dec; 74(6):439-45. PubMed ID: 17157099
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
